{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:54:32Z","timestamp":1773420872094,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,6,28]],"date-time":"2012-06-28T00:00:00Z","timestamp":1340841600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2369-13-49","type":"journal-article","created":{"date-parts":[[2012,6,28]],"date-time":"2012-06-28T14:14:21Z","timestamp":1340892861000},"source":"Crossref","is-referenced-by-count":17,"title":["Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial"],"prefix":"10.1186","volume":"13","author":[{"given":"Inger H","family":"Bleskestad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Bergrem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Godang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lasse G","family":"G\u00f8ransson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,28]]},"reference":[{"key":"322_CR1","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","volume":"52","author":"F Tentori","year":"2008","unstructured":"Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, Young EW, Akizawa T, Akiba T, Pisoni RL, et al: Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2008, 52: 519-530. 10.1053\/j.ajkd.2008.03.020.","journal-title":"Am J Kidney Dis"},{"key":"322_CR2","unstructured":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int. 2009, 76 (Suppl 103): S1-S130."},{"key":"322_CR3","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1093\/ndt\/gfn592","volume":"24","author":"F Tentori","year":"2009","unstructured":"Tentori F, Albert JM, Young EW, Blayney MJ, Robinson BM, Pisoni RL, Akiba T, Greenwood RN, Kimata N, Levin NW, et al: The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant. 2009, 24: 963-972.","journal-title":"Nephrol Dial Transplant"},{"key":"322_CR4","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.2215\/CJN.08241109","volume":"5","author":"P Evenepoel","year":"2010","unstructured":"Evenepoel P, Meijers B, Viaene L, Bammens B, Claes K, Kuypers D, Vanderschueren D, Vanrenterghem Y: Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism. Clin J Am Soc Nephrol. 2010, 5: 1268-1276. 10.2215\/CJN.08241109.","journal-title":"Clin J Am Soc Nephrol"},{"key":"322_CR5","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1681\/ASN.2005010052","volume":"16","author":"O Gutierrez","year":"2005","unstructured":"Gutierrez O, Isakova T, Rhee E, Shah A, Holmes J, Collerone G, Juppner H, Wolf M: Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol. 2005, 16: 2205-2215. 10.1681\/ASN.2005010052.","journal-title":"J Am Soc Nephrol"},{"key":"322_CR6","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00467-009-1260-4","volume":"25","author":"M Kuro-o","year":"2010","unstructured":"Kuro-o M: Overview of the FGF23-Klotho axis. Pediatr Nephrol. 2010, 25: 583-590. 10.1007\/s00467-009-1260-4.","journal-title":"Pediatr Nephrol"},{"key":"322_CR7","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/ki.2009.414","volume":"77","author":"H Komaba","year":"2010","unstructured":"Komaba H, Goto S, Fujii H, Hamada Y, Kobayashi A, Shibuya K, Tominaga Y, Otsuki N, Nibu K, Nakagawa K, et al: Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients. Kidney Int. 2010, 77: 232-238. 10.1038\/ki.2009.414.","journal-title":"Kidney Int"},{"key":"322_CR8","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMoa0706130","volume":"359","author":"OM Gutierrez","year":"2008","unstructured":"Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Juppner H, Wolf M: Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med. 2008, 359: 584-592. 10.1056\/NEJMoa0706130.","journal-title":"N Engl J Med"},{"key":"322_CR9","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1001\/jama.2011.826","volume":"15","author":"T Isakova","year":"2011","unstructured":"Isakova T, Xie H, Yang W, Xie D, Anderson AH, Scialla J, Wahl P, Gutierrez OM, Steigerwalt S, He J, Schwartz S, Lo J, Ojo A, Sondheimer J, Hsu C-Y, Lash J, Leonard M, Kusek JW, Feldman HI, Wolf M: Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA. 2011, 15: 2432-2439.","journal-title":"JAMA"},{"key":"322_CR10","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1016\/j.numecd.2008.03.003","volume":"18","author":"V Savica","year":"2008","unstructured":"Savica V, Calo LA, Monardo P, Caldarera R, Cavaleri A, Santoro D, Muraca U, Mallamace A, Bellinghieri G: High phosphate content beverages in dialysis patients: relevance for hyperphosphatemia and cardiovascular risk. Nutr Metab Cardiovasc Dis. 2008, 18: e39-e40. 10.1016\/j.numecd.2008.03.003.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"322_CR11","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999, 130: 461-470.","journal-title":"Ann Intern Med"},{"key":"322_CR12","first-page":"467","volume-title":"Practical Statistics for Medical Research","author":"DG Altman","year":"1999","unstructured":"Altman DG: Clinical trials. Practical Statistics for Medical Research. 1999, Chapman and Hall\/CRC, London, 467-471."},{"key":"322_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/0470854596","volume-title":"Cross-over Trials in Clinical Research","author":"S Senn","year":"2002","unstructured":"Senn S: The AB\/BA design with normal data. Cross-over Trials in Clinical Research. 2002, John Wiley and Sons Ltd, Chichester, England, 42-47. 2","edition":"2"},{"key":"322_CR14","doi-asserted-by":"publisher","first-page":"c94","DOI":"10.1159\/000086347","volume":"101","author":"H Nishi","year":"2005","unstructured":"Nishi H, Nii-Kono T, Nakanishi S, Yamazaki Y, Yamashita T, Fukumoto S, Ikeda K, Fujimori A, Fukagawa M: Intravenous calcitriol therapy increases serum concentrations of fibroblast growth factor-23 in dialysis patients with secondary hyperparathyroidism. Nephron Clin Pract. 2005, 101: c94-c99. 10.1159\/000086347.","journal-title":"Nephron Clin Pract"},{"key":"322_CR15","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1681\/ASN.2007060673","volume":"19","author":"T Isakova","year":"2008","unstructured":"Isakova T, Gutierrez O, Shah A, Castaldo L, Holmes J, Lee H, Wolf M: Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD. J Am Soc Nephrol. 2008, 19: 615-623. 10.1681\/ASN.2007060673.","journal-title":"J Am Soc Nephrol"},{"key":"322_CR16","volume-title":"Sample size calculations. The little handbook of statistical practice","author":"GE Dallal","year":"2008","unstructured":"Dallal GE: Sample size calculations. The little handbook of statistical practice. 2008, \n                    http:\/\/www.lib.westfield.ma.edu\/webmls.htm\n                    \n                  ,"},{"key":"322_CR17","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1210\/jc.2002-021105","volume":"87","author":"Y Yamazaki","year":"2002","unstructured":"Yamazaki Y, Okazaki R, Shibata M, Hasegawa Y, Satoh K, Tajima T, Takeuchi Y, Fujita T, Nakahara K, Yamashita T, Fukumoto S: Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia. J Clin Endocrinol Metab. 2002, 87: 4957-4960. 10.1210\/jc.2002-021105.","journal-title":"J Clin Endocrinol Metab"},{"key":"322_CR18","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1210\/jc.2004-1039","volume":"90","author":"SL Ferrari","year":"2005","unstructured":"Ferrari SL, Bonjour JP, Rizzoli R: Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab. 2005, 90: 1519-1524.","journal-title":"J Clin Endocrinol Metab"},{"key":"322_CR19","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1359\/jbmr.060507","volume":"21","author":"SM Burnett","year":"2006","unstructured":"Burnett SM, Gunawardene SC, Bringhurst FR, Juppner H, Lee H, Finkelstein JS: Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res. 2006, 21: 1187-1196. 10.1359\/jbmr.060507.","journal-title":"J Bone Miner Res"},{"key":"322_CR20","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1210\/jc.2006-0021","volume":"91","author":"DM Antoniucci","year":"2006","unstructured":"Antoniucci DM, Yamashita T, Portale AA: Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab. 2006, 91: 3144-3149. 10.1210\/jc.2006-0021.","journal-title":"J Clin Endocrinol Metab"},{"key":"322_CR21","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2215\/CJN.04730510","volume":"6","author":"MG Vervloet","year":"2011","unstructured":"Vervloet MG, van Ittersum FJ, Buttler RM, Heijboer AC, Blankenstein MA, ter Wee PM: Effects of dietary phosphate and calcium intake on fibroblast growth factor-23. Clin J Am Soc Nephrol. 2011, 6: 383-389. 10.2215\/CJN.04730510.","journal-title":"Clin J Am Soc Nephrol"},{"key":"322_CR22","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/ndt\/gfq419","volume":"26","author":"T Isakova","year":"2011","unstructured":"Isakova T, Gutierrez OM, Smith K, Epstein M, Keating LK, Juppner H, Wolf M: Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease. Nephrol Dial Transplant. 2011, 26: 584-591. 10.1093\/ndt\/gfq419.","journal-title":"Nephrol Dial Transplant"},{"key":"322_CR23","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1093\/ndt\/gfr144","volume":"26","author":"E Gonzalez-Parra","year":"2011","unstructured":"Gonzalez-Parra E, Gonzalez-Casaus ML, Galan A, Martinez-Calero A, Navas V, Rodriguez M, Ortiz A: Lanthanum carbonate reduces FGF23 in chronic kidney disease stage 3 patients. Nephrol Dial Transplant. 2011, 26: 2567-2571. 10.1093\/ndt\/gfr144.","journal-title":"Nephrol Dial Transplant"},{"key":"322_CR24","doi-asserted-by":"publisher","first-page":"286","DOI":"10.2215\/CJN.05420709","volume":"5","author":"RB Oliveira","year":"2010","unstructured":"Oliveira RB, Cancela AL, Graciolli FG, Dos Reis LM, Draibe SA, Cuppari L, Carvalho AB, Jorgetti V, Canziani ME, Moyses RM: Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?. Clin J Am Soc Nephrol. 2010, 5: 286-291. 10.2215\/CJN.05420709.","journal-title":"Clin J Am Soc Nephrol"},{"key":"322_CR25","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/ki.2010.543","volume":"79","author":"AS Dusso","year":"2011","unstructured":"Dusso AS, Tokumoto M: Defective renal maintenance of the vitamin D endocrine system impairs vitamin D renoprotection: a downward spiral in kidney disease. Kidney Int. 2011, 79: 715-729. 10.1038\/ki.2010.543.","journal-title":"Kidney Int"},{"key":"322_CR26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T: FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res. 2004, 19: 429-435.","journal-title":"J Bone Miner Res"},{"key":"322_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1152\/physiol.00034.2008","volume":"24","author":"T Berndt","year":"2009","unstructured":"Berndt T, Kumar R: Novel mechanisms in the regulation of phosphorus homeostasis. Physiology (Bethesda). 2009, 24: 17-25. 10.1152\/physiol.00034.2008.","journal-title":"Physiology (Bethesda)"},{"key":"322_CR28","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1038\/ki.2011.23","volume":"79","author":"E Slatopolsky","year":"2011","unstructured":"Slatopolsky E: The intact nephron hypothesis: the concept and its implications for phosphate management in CKD-related mineral and bone disorder. Kidney Int. 2011, 79: S3-S8.","journal-title":"Kidney Int"},{"key":"322_CR29","doi-asserted-by":"publisher","first-page":"11085","DOI":"10.1073\/pnas.0704446104","volume":"104","author":"T Berndt","year":"2007","unstructured":"Berndt T, Thomas LF, Craig TA, Sommer S, Li X, Bergstralh EJ, Kumar R: Evidence for a signaling axis by which intestinal phosphate rapidly modulates renal phosphate reabsorption. Proc Natl Acad Sci U S A. 2007, 104: 11085-11090. 10.1073\/pnas.0704446104.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"322_CR30","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00774-007-0779-3","volume":"25","author":"N Ito","year":"2007","unstructured":"Ito N, Fukumoto S, Takeuchi Y, Takeda S, Suzuki H, Yamashita T, Fujita T: Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans. J Bone Miner Metab. 2007, 25: 419-422. 10.1007\/s00774-007-0779-3.","journal-title":"J Bone Miner Metab"},{"key":"322_CR31","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1038\/sj.ki.5002000","volume":"70","author":"Y Nishida","year":"2006","unstructured":"Nishida Y, Taketani Y, Yamanaka-Okumura H, Imamura F, Taniguchi A, Sato T, Shuto E, Nashiki K, Arai H, Yamamoto H, Takeda E: Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men. Kidney Int. 2006, 70: 2141-2147.","journal-title":"Kidney Int"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-13-49\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-13-49.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-13-49","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-13-49.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T03:40:20Z","timestamp":1548214820000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-13-49"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,28]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["322"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-13-49","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,28]]},"article-number":"49"}}